HSBC Holdings’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Sell |
28,309
-42,525
| -60% | -$157K | ﹤0.01% | 2366 |
|
|
2025
Q1 | $135K | Buy |
70,834
+829
| +1% | +$1.58K | ﹤0.01% | 2279 |
|
|
2024
Q4 | $131K | Buy |
70,005
+15,032
| +27% | +$28K | ﹤0.01% | 2412 |
|
|
2024
Q3 | $72.6K | Buy |
+54,973
| New | +$72.6K | ﹤0.01% | 2458 |
|
|
2022
Q2 | – | Sell |
-69,107
| Closed | -$49K | – | 2771 |
|
|
2022
Q1 | $49K | Sell |
69,107
-25,028
| -27% | -$17.7K | ﹤0.01% | 2814 |
|
|
2021
Q4 | $215K | Buy |
94,135
+55,073
| +141% | +$126K | ﹤0.01% | 2512 |
|
|
2021
Q3 | $112K | Hold |
39,062
| – | – | ﹤0.01% | 2402 |
|
|
2021
Q2 | $148K | Hold |
39,062
| – | – | ﹤0.01% | 2369 |
|
|
2021
Q1 | $132K | Sell |
39,062
-13,062
| -25% | -$44.1K | ﹤0.01% | 2236 |
|
|
2020
Q4 | $146K | Sell |
52,124
-11,338
| -18% | -$31.8K | ﹤0.01% | 2445 |
|
|
2020
Q3 | $158K | Buy |
63,462
+35,532
| +127% | +$88.5K | ﹤0.01% | 2096 |
|
|
2020
Q2 | $379K | Sell |
27,930
-2,189
| -7% | -$29.7K | ﹤0.01% | 1648 |
|
|
2020
Q1 | $234K | Buy |
30,119
+4,264
| +16% | +$33.1K | ﹤0.01% | 1789 |
|
|
2019
Q4 | $168K | Sell |
25,855
-144,656
| -85% | -$940K | ﹤0.01% | 2310 |
|
|
2019
Q3 | $668K | Buy |
+170,511
| New | +$668K | ﹤0.01% | 1604 |
|